Flordipine

This classification denotes a calcium channel blocker with the molecular formula C26H33F3N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8UFI7XI7R, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-1-(2-(4-morpholinyl)ethyl)-4-(2-(trifluoromethyl)phenyl)-, diethyl ester but generally known as flordipine, which bears US NIH Compound Identifier 53699. European Medicines Agency schedules Flordipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07649MIG. The term FLORDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). FLORDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flordipine under HS 29349990 and SITC 51579. As of Q4 2014, FLORDIPINE remains the US FDA Preferred Term for this commodity. Flordipine bears US NLM identifiers UMLS ID C0060464 and NCI Concept Code C81689. SMILES: FC(F)(F)c1c(C2C(=C(N(CCN3CCOCC3)C(=C2C(=O)OCC)C)C)C(=O)OCC)cccc1.